Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”


HHS - 803 - Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases - Authorized by Law
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameBoard of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney DiseasesAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number803
Original Establishment Date11/20/1985Committee StatusChartered
Actual Termination Date Committee URLhttps://www.niddk.nih.gov/about-niddk/advisory-...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*8
Current Charter Date12/1/1986Designated Fed Officer Position Title*SCIENTIFIC DIRECTOR
Date Of Renewal Charter Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*MICHAEL
Exempt From Renewal*YesDesignated Federal Officer Middle NameW.
Specific Termination AuthorityDesignated Federal Officer Last Name*KRAUSE
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixPH.D.
Specific Establishment Authority*42 U.S.C. 282(b)(16)Designated Federal Officer Phone*(301) 402-7044
Effective Date Of Authority*11/20/1985Designated Federal Officer Fax*(301) 496-0201
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*michaelkr@mail.nih.gov
Committee Type*Continuing
Presidential*No
Committee Function*Other Committee
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*Section 402(b)(3) of the Public Health Service Act states that ...the Director, NIH...shall assure that research at...the National Institutes of Health is subject to review in accordance with section 492. Section 492(b) states that the Director of NIH shall establish procedures for periodic technical and scientific peer review of research at the National Institutes of Health. This Board assesses the quality of the Institute intramural research programs and evaluates the productivity and performance of staff scientists, necessary functions for the operation of a highly effective intramural research program. The Board is composed of recognized biomedical and or behavioral research authorities who represent the forefront of research and technical knowledge and who provide evaluation and peer review of Institute laboratories and staff scientists in the following areas: diabetes, endocrinology, and metabolism; digestive diseases and nutritional disorders; and kidney, urologic and hematological diseases. The Board continues to provide indispensable evaluation and advisory functions in the science management of the intramural research programs. The Board normally holds two formal meetings each year for peer review of each laboratory and the chairman and individual Board members are frequently consulted for advice on staff appointments and program development. In 2021, two meetings were held; one in October 2021 and the other in April 2022. During the October 2021 meeting, the board reviewed the following labs: Kidney Disease Branch, Laboratory of Chemical Physics and Liver Diseases Branch and Laboratory of Biochemistry and Genetics. The Board reviewed twelve (12) Principal Investigators, one (1) Acting Clinical Director, two (2) Stadtman Investigators and one (1) Investigator. During the April 2022 meeting, the Board reviewed: 2. Molecular Medicine Branch, and solo investigators from the following branches Phoenix Epidemiology and Clinical Research Branch and Diabetes, Endocrinology and Obesity Branch. Two Stadtman Investigators Laboratory of Cell and Molecular Biology and Laboratory of Molecular Biology. Two Stadtman Investigators Laboratory of Cell and Molecular Biology and Laboratory of Molecular Biology reviewed on April 29, 2022. The Board reviewed four (4) Principal Investigators and two (2) Stadtman Investigators. The Board provides to the National Diabetes and Digestive and Kidney Diseases Advisory Council for review a description of its activities.
How is membership balanced?*The Board consists of eight members, approximately, who are outstanding authorities knowledgeable in the specialized fields of diabetes, kidney diseases, molecular biology, chemistry, chemical physics, genetics, endocrinology, biochemistry and nutrition. The advisory role of the Board is scientific and substantive. The Board, through periodic visits to the laboratories, assesses the research in progress and evaluates productivity and performance of staff scientists.
How frequent & relevant are cmte mtgs?*The Board met twice during this reporting period. The Board holds approximately two meetings each year for the peer review of intramural laboratories on a rotating basis as required by the PHS Act.
Why advice can't be obtained elsewhere?*The Board is composed of recognized biomedical research authorities from outside the NIH in order to secure unbiased and objective evaluation of intramural research programs. Their recommendations are invaluable because the complex nature of research in each laboratory requires a unique balance and breadth of expertise not available on the NIH staff or from other established resources.
Why close or partially close meetings?The meetings of the Board were partially closed for the review, discussion, and evaluation of individual programs and projects conducted by the Institute, including consideration of personnel qualifications and performance, the competence of individual investigators, and similar items, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Section 552b(c)(6) of the Government in the Sunshine Act permits the closing of meetings where discussions could reveal personal information, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Recommendation RemarksCommittee Function: Other - Scientific and Technical Peer Review.

Reports: This committee did not produce any reports during this reporting period.

Note that the Designated Federal Officer and Committee Decision Maker positions are both held by the Scientific Director of the Institute. The Board advises the Institute on issues associated with the Institute's Intramural Research Program, which is the primary responsibility of the Scientific Director.

The Chair, Dr. Jorge Bezerra's term ended on 6/30/2022. Dr. Jay Horton was re-assigned as chair and will occupy the position until his term ends on 6/30/2024. This is why the Charter states eight potential members, but this ACR lists five.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*NoAction Reorganize Priorities*No
Outcome Trust In GovernmentNoAction Reallocate ResourcesNo
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryNoAction OtherYes
Outcome Increased Customer SatisfactionNoAction CommentThe Scientific Director and other NIH officials use the recommendations made by the BSC in evaluating the quality of intramural research programs including scientific priorities and resources available. No changes were made to existing laboratory research priorities or resources.
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentNIH supported basic and clinical research accomplishments often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseases.Grants Review CommentAlthough grant reviews are included in the duties of the Board, there were no grant reviews performed during this fiscal year.
Number Of Recommendations*80Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentDuring each meeting the members evaluate the scientific programs of three or four Laboratories/Branches (every Lab/Branch is evaluated once every four years) and reviewed the progress of junior scientists at the midpoint of or during the final year of the six-to-eight year period of their tenure track appointment.Access Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentInformation on the research funded by NIH is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentInformation on the research funded by NIH is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.Access OtherNo
Agency Feedback*YesAccess CommentContact Designated Federal Officer.
Agency Feedback Comment*Information resulting from closed Board of Scientific Counselors meetings is subject to the Freedom of Information Act. The public can view information on NIH Intramural Research Reports found on the NIH Intramural Research Sourcebook website located at https://oir.nih.gov/sourcebook/intramural-research-communications-resources/annual-reports-bibliographies/Narrative Description*The goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability, from the rarest genetic disorder to the common cold. The NIH mission is to uncover new knowledge that will lead to better health for everyone. NIH works toward that mission by conducting research in its own laboratories. Section 402(b)(3) of the Public Health Service Act states that "the Director, NIH...shall assure that research at...the National Institutes of Health is subject to review in accordance with section 492." Section 492(b) states that the "Director of NIH shall establish procedures for periodic technical and scientific peer review of research at the National Institutes of Health. The mission of the Board of Scientific Counselors is to assess the quality of the Institute's intramural research programs and to evaluate the productivity and performance of intramural scientists and shall also, as requested by the Director, NIH, undertake peer review of extramural funding applications as required by section 492 of the Public Health Service Act, as amended."
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$4,400.00Est Payments to Non-Fed Members Next FY*$4,400.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY*$0.00
Payments to Federal Staff*$171,336.00Estimated Payments to Federal Staff*$175,962.00
Payments to Consultants*$7,800.00Est. Payments to Consultants Next FY*$7,800.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$8,830.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$24,724.00
Other Costs$0.00Est. Other Costs Next FY*$0.00
Total Costs$183,536.00Est. Total Next FY*$221,716.00
Date Cost Last Modified9/16/2022 9:25 AMEst. Fed Staff Support Next FY*1.00
Federal Staff Support (FTE)*1.00Est Cost RemarksMeetings were held virtually in FY22 due to the ongoing COVID-19 pandemic. Projected costs for FY23 were increased in the event that in-person/hybrid meetings resume.
Cost RemarksDue to the COVID-19 pandemic, FY2022 meetings were virtual only, which reduced committee operating costs. All peer review meetings in FY 2022 were held via Zoom.  
Hide Section - Interest Areas

Interest Areas

Category
Area
Health
Health Care
Medicine
Health and Health Research
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-040377Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2021
 COM-038655Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2020
 COM-036526Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2019
 COM-034734Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2018
 COM-001687Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2017
 COM-002667Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2016
 COM-004039Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2015
 COM-004382Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2014
 COM-005919Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2013
 COM-006599Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2012
 COM-008179Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2011
 COM-008669Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2010
 COM-010301Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2009
 COM-010724Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2008
 COM-011881Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2007
 COM-012855Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2006
 COM-013990Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2005
 COM-014495Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2004
 COM-015991Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2003
 COM-016684Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2002
 COM-017614Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2001
 COM-018527Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases2000
 COM-019587Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases1999
 COM-020370Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases1998
 COM-021674Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases1997